Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

The race for gigantism is redrawing the map of global sports infrastructure. With a projected capacity of 135,000 seats, the future Trong Dong in Vietnam is set to top a ranking long dominated by ...

The largest-ever communications satellite of its kind took a major step toward operation Tuesday: operator AST SpaceMobile announced the record-breaking spacecraft, whimsically called BlueBird 6, has ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Ludi Akue discusses how the tech sector’s ...

Bigger than most walls and designed to double as art, Samsung debuted a 130-inch Micro RGB TV at the Consumer Electronics Show (CES) 2026, its largest and most advanced display yet. Samsung unveiled ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

The world has a new most populous city. Indonesia’s capital, Jakarta, tops a ranking that is increasingly dominated by Asia. It edged out Bangladesh’s capital, Dhaka, and Japan's Tokyo to earn the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...